Pharm 34 Flashcards


Set Details Share
created 8 months ago by moldyvoldy
updated 5 weeks ago by moldyvoldy
show moreless
Page to share:
Embed this setcancel
COPY
code changes based on your size selection
Size:
X
Show:

1

A clinician draws blood for a coagulation assay but wants to prevent clotting in the tube. Which additive is most appropriate?

A. Tissue plasminogen activator
B. Calcium chelator
C. Vitamin K analogue
D. Direct thrombin inhibitor

B. Calcium chelator

2

A patient with persistent postoperative oozing is given aminocaproic acid. The drug most directly decreases formation of which enzyme?

A. Thrombin
B. Factor Xa
C. Plasmin
D. Protein C

C. Plasmin

3

Aminocaproic acid is best understood as a structural analogue of which amino acid?

A. Lysine
B. Glycine
C. Serine
D. Arginine

A. Lysine

4

The principal hemostatic process inhibited by aminocaproic acid is:

A. Platelet adhesion
B. Fibrinolysis
C. Vitamin K recycling
D. Fibrin cross-linking

B. Fibrinolysis

5

Which heparin preparation has the greater effect on thrombin inhibition?

A. Fondaparinux
B. Low-molecular-weight heparin
C. High-molecular-weight heparin
D. Warfarin

C. High-molecular-weight heparin

6

Compared with high-molecular-weight heparin, low-molecular-weight heparin has less effect on:

A. Platelet cyclooxygenase
B. Direct thrombin inhibition
C. Protein C activation
D. Vitamin K epoxide reductase

B. Direct thrombin inhibition

7

Heparin begins its anticoagulant action by binding to:

A. Antithrombin III
B. Factor VII
C. Protein S
D. Plasminogen

A. Antithrombin III

8

After binding its target protein, heparin most directly accelerates inactivation of:

A. VIIa and IXa
B. II and Xa
C. XI and XII
D. Va and VIIIa

B. II and Xa

9

Which pattern most accurately describes high-molecular-weight heparin?

A. Predominant Xa inhibition
B. Platelet ADP blockade
C. II and Xa inhibition
D. Oral Xa blockade

C. II and Xa inhibition

10

Which pattern most accurately describes low-molecular-weight heparin?

A. Mainly factor Xa inhibition
B. Mainly factor II inhibition
C. P2Y12 receptor blockade
D. Vitamin K antagonism

A. Mainly factor Xa inhibition

11

Which drug is a low-molecular-weight heparin?

A. Argatroban
B. Enoxaparin
C. Fondaparinux
D. Abciximab

B. Enoxaparin

12

A hospitalized patient on a continuous heparin infusion should be followed primarily with which laboratory study?

A. PT
B. INR
C. Bleeding time
D. PTT

D. PTT

13

Five days after starting heparin, a patient develops thrombocytopenia and a new painful swollen leg. Which complication is most likely?

A. Disseminated fibrinolysis
B. Heparin-induced thrombocytopenia
C. Warfarin skin necrosis
D. Aspirin resistance

B. Heparin-induced thrombocytopenia

14

A patient develops heparin-induced thrombocytopenia with new thrombosis. Which alternative is most appropriate?

A. Argatroban
B. Phytonadione
C. Abciximab
D. Enoxaparin

D. Enoxaparin

15

A major long-term adverse effect of prolonged heparin therapy is:

A. Osteoporosis
B. Hemarthrosis
C. Folate deficiency
D. Hemolytic anemia

A. Osteoporosis

16

Another recognized long-term consequence of heparin exposure is:

A. Hyperaldosteronism
B. Mineralocorticoid deficiency
C. Copper deficiency
D. Nephrogenic diabetes insipidus

B. Mineralocorticoid deficiency

17

Which complication pair is classically associated with prolonged heparin therapy?

A. Cataracts and glaucoma
B. Ulcers and perforation
C. Fractures and osteoporosis
D. Neuropathy and myopathy

C. Fractures and osteoporosis

18

Heparin is generally contraindicated in a patient who has very recently undergone:

A. Vaccination
B. Surgery
C. Colonoscopy
D. Hemodialysis

B. Surgery

19

Which drug is highly specific for factor Xa and is especially effective for prevention and treatment of venous thromboembolism?

A. Dabigatran
B. Cilostazol
C. Fondaparinux
D. Clopidogrel

C. Fondaparinux

20

Which drug is an oral factor Xa inhibitor?

A. Rivaroxaban
B. Eptifibatide
C. Ticlopidine
D. Hirudin

A. Rivaroxaban

21

Which additional drug also belongs to the oral factor Xa inhibitor class?

A. Prasugrel
B. Edoxaban
C. Bivalirudin
D. Abciximab

B. Edoxaban

22

Which agent is another oral factor Xa inhibitor?

A. Betrixaban
B. Tinzaparin
C. Argatroban
D. Tirofiban

A. Betrixaban

23

Which agent is a direct thrombin inhibitor?

A. Apixaban
B. Clopidogrel
C. Bivalirudin
D. Fondaparinux

C. Bivalirudin

BAD

24

Which agent is a direct thrombin inhibitor?

A. Argatroban
B. Cilostazol
C. Prasugrel
D. Tirofiban

A. Argatroban

BAD

25

Which agent is a direct thrombin inhibitor?

A. Prasugrel
B. Cilostazol
C. Dabigatran
D. Tirofiban

C. Dabigatran

BAD

26

A patient requires inhibition of ADP-induced platelet aggregation after arterial thrombosis. Which drug fits best?

A. Abciximab
B. Clopidogrel
C. Rivaroxaban
D. Hirudin

B. Clopidogrel

ADP CTP

27

Which additional drug shares that ADP-mediated antiplatelet mechanism?

A. Ticlopidine
B. Eptifibatide
C. Betrixaban
D. Enoxaparin

A. Ticlopidine

ADP CTP

28

Which drug inhibits ADP-induced platelet aggregation?

A. Fondaparinux
B. Eptifibatide
C. Prasugrel
D. Warfarin

C. Prasugrel

ADP CTP

29

Which platelet inhibitor works by blocking glycoprotein IIb/IIIa receptors?

A. Prasugrel
B. Dabigatran
C. Tirofiban
D. Warfarin

C. Tirofiban

EAT GP2

30

Which additional drug works by the same glycoprotein IIb/IIIa mechanism?

A. Abciximab
B. Apixaban
C. Cilostazol
D. Ticlopidine

A. Abciximab

EAT GP2

31

A smoker with exertional calf pain is started on a phosphodiesterase inhibitor to improve symptoms. Which drug was most likely prescribed?

A. Prasugrel
B. Cilostazol
C. Fondaparinux
D. Edoxaban

B. Cilostazol

32

A patient with warfarin excess develops active bleeding and marked overanticoagulation. Which treatment pair is most appropriate?

A. Menadione and platelets
B. Protamine and cryoprecipitate
C. Phytonadione and fresh frozen plasma
D. Aspirin and plasma

C. Phytonadione and fresh frozen plasma

33

Which vitamin preparation should never be used to treat warfarin overdose?

A. Vitamin K1 (Phytonadione)
B. Vitamin K2
C. Vitamin K3 (Menadione)
D. Folinic acid

C. Vitamin K3 (Menadione)

34

Which drug is also an oral factor Xa inhibitor?

A. Argatroban
B. Apixaban
C. Hirudin
D. Abciximab

B. Apixaban

35

Ticlopidine: which adverse effect is most classically associated with this drug?

A. Hemolysis
B. Leukopenia
C. Polycythemia
D. Eosinophilia

B. Leukopenia

36

Which drug is another example of a low-molecular-weight heparin?

A. Dalteparin
B. Dabigatran
C. Abciximab
D. Menadione

A. Dalteparin

37

Which additional drug also belongs to the low-molecular-weight heparin group?

A. Tirofiban
B. Tinzaparin
C. Argatroban
D. Cilostazol

B. Tinzaparin

38

Which factor Xa inhibitor has a heparin-like mechanism yet does not cause HIT?

A. Fondaparinux
B. Rivaroxaban
C. Apixaban
D. Edoxaban

A. Fondaparinux

39

A patient receiving unfractionated heparin develops severe bleeding. Which agent is most appropriate for immediate reversal?

A. Idarucizumab
B. Phytonadione
C. Protamine sulfate
D. Fresh frozen plasma

C. Protamine sulfate

40

Warfarin impairs γ-carboxylation of glutamate residues on which coagulation-related factor?

A. Factor VIII
B. Factor VII
C. Factor V
D. Factor XII

B. Factor VII

41

Warfarin also decreases γ-carboxylation of which additional factor?

A. Factor XI
B. Factor XIII
C. Factor IX
D. Factor VIII

C. Factor IX

42

Warfarin decreases synthesis of functional clotting factors by inhibiting:

A. Thrombin
B. VKORC1
C. Plasmin
D. Antithrombin III

B. VKORC1

43

Which endogenous anticoagulant protein is reduced by warfarin and contributes to its initial paradoxical hypercoagulability?

A. Protein C
B. Protein M
C. Protein S
D. Protein H

A. Protein C

44

Which additional endogenous anticoagulant protein undergoes impaired γ-carboxylation with warfarin therapy?

A. Protein A
B. Protein M
C. Protein S
D. Protein H

C. Protein S

45

A patient presents with an acute pulmonary embolism and needs immediate anticoagulation. Is warfarin the best initial monotherapy?

A. Yes, because it is rapid
B. Yes, if INR is high
C. No, use aspirin first
D. No, use heparin first

D. No, use heparin first

46

Warfarin is avoided as sole initial therapy in acute thrombosis because it can transiently produce:

A. Hypercoagulability
B. Fibrinolysis
C. Thrombocytosis
D. Vasodilation

A. Hypercoagulability

47

Which statement best describes warfarin use during pregnancy?

A. Safe after first trimester
B. Safe with folate supplementation
C. Contraindicated; crosses placenta
D. Contraindicated; poor absorption

C. Contraindicated; crosses placenta

48

A patient newly started on warfarin. Which complication is most likely?

A. Cholesterol embolization
B. Skin necrosis
C. Calciphylaxis
D. Erythema nodosum

B. Skin necrosis

49

Warfarin therapy is followed primarily with which laboratory test?

A. PTT
B. Bleeding time
C. Thrombin time
D. PT

D. PT

50

Which cytochrome P450 enzyme is most important in warfarin metabolism?

A. CYP3A4
B. CYP2C9
C. CYP2D6
D. CYP1A2

B. CYP2C9

51

What INR range is expected for a patient therapeutically anticoagulated with warfarin, based on this material?

A. 1.0–1.5
B. 1.5–2.0
C. 2.0–3.5
D. 3.5–5.0

C. 2.0–3.5

52

A patient on warfarin presents with major bleeding and marked overanticoagulation. Which reversal strategy is most appropriate?

A. Vitamin K
B. Protamine and plasma
C. Idarucizumab and plasma
D. Plasma, vitamin K, factor VII

D. Plasma, vitamin K, factor VII

53

Which oral anticoagulant directly inhibits factor Xa?

A. Rivaroxaban
B. Dabigatran
C. Warfarin
D. Bivalirudin

A. Rivaroxaban

54

Rivaroxaban is primarily metabolized by which enzyme?

A. CYP2C9
B. CYP3A4
C. CYP2E1
D. CYP1A2

B. CYP3A4

55

A patient wants an oral anticoagulant that usually does not require routine laboratory monitoring. Which class best fits?

A. Direct thrombin inhibitors
B. Vitamin K antagonists
C. Oral direct Xa inhibitors
D. Unfractionated heparins

C. Oral direct Xa inhibitors

56

Which medication suffix most strongly suggests an oral direct factor Xa inhibitor?

A. -parin
B. -gatran
C. -plase
D. -xaban

D. -xaban

57

Direct factor Xa inhibitors are commonly used for which arrhythmia?

A. Ventricular fibrillation
B. Atrial fibrillation
C. Torsades de pointes
D. Sinus bradycardia

B. Atrial fibrillation

58

Which direct factor Xa inhibitor is specifically noted here as not fitting that atrial fibrillation indication, especially with poor renal function?

A. Rivaroxaban
B. Apixaban
C. Edoxaban
D. Betrixaban

C. Edoxaban

59

A patient with dabigatran-associated hemorrhage requires urgent reversal. Which agent should be used?

A. Protamine sulfate
B. Idarucizumab
C. Phytonadione
D. Tranexamic acid

B. Idarucizumab

60

what can we call strepokinase and urokinase?

______-busters

clot

61

Streptokinase and urokinase exert their effects primarily by:

A. Blocking thrombin
B. Chelating calcium
C. Activating plasmin
D. Inhibiting VKORC1

C. Activating plasmin

62

Alteplase and tenecteplase are best classified as:

A. Direct Xa inhibitors
B. Fibrinolytics
C. Platelet antagonists
D. Vitamin K analogues

B. Fibrinolytics

63

Which description best distinguishes alteplase and tenecteplase from streptokinase and urokinase?

A. Recombinant t-PAs
B. Oral thrombin blockers
C. Heparin analogues
D. Antiplatelet antibodies

A. Recombinant t-PAs

64

A patient with STEMI receives alteplase. The drug’s immediate therapeutic goal is:

A. Lower factor VII
B. Block platelet ADP
C. Accelerate fibrinolysis
D. Reverse protein C loss

C. Accelerate fibrinolysis

65

A patient with acute coronary syndrome is given an antiplatelet drug that irreversibly acetylates its target enzyme in platelets. Which drug was most likely administered?

A. Clopidogrel
B. Aspirin
C. Tirofiban
D. Cilostazol

B. Aspirin

66

The antiplatelet effect of aspirin is primarily due to inhibition of:

A. COX
B. PDE-3
C. P2Y12
D. Thrombin

A. COX

67

By inhibiting cyclooxygenase in platelets, aspirin most directly decreases release of:

A. Prostacyclin
B. Fibrinogen
C. Thromboxane A2
D. Plasminogen

C. Thromboxane A2

68

Which pair shares the same principal mechanism of antiplatelet action?

A. Aspirin and abciximab
B. Clopidogrel and ticlopidine
C. Cilostazol and warfarin
D. Alteplase and aspirin

B. Clopidogrel and ticlopidine

69

Clopidogrel reduces platelet function primarily by blocking the:

A. GPIIb/IIIa receptor
B. COX enzyme
C. P2Y12 receptor
D. PAR-1 receptor

C. P2Y12 receptor

70

Inhibition of the platelet P2Y12 receptor most directly reduces platelet:

A. Adhesion
B. Aggregation
C. Degranulation
D. Vasoconstriction

B. Aggregation

71

A patient with unstable angina is started on an oral antiplatelet agent that blocks ADP signaling. Which drug best fits?

A. Clopidogrel
B. Eptifibatide
C. Dipyridamole
D. Rivaroxaban

A. Clopidogrel

72

Which acute coronary syndrome is specifically included among the indications for clopidogrel in this material?

A. Stable bradycardia
B. NSTEMI
C. Atrial flutter
D. Mitral stenosis

B. NSTEMI

73

Which additional condition is listed here as an indication for clopidogrel?

A. STEMI
B. DVT
C. PE
D. AFib

A. STEMI

74

Clopidogrel requires bioactivation predominantly through which enzyme?

A. CYP3A4
B. CYP2D6
C. CYP2C19
D. CYP1A2

C. CYP2C19

75

In addition to leukopenia, ticlopidine has also been associated with:

A. DIC
B. TTP
C. HIT
D. ITP

B. TTP

76

Thrombotic Thrombocytopenic Purpura, a rare, life-threatening blood disorder characterized by ___ ___ forming in small vessels throughout the body, causing low platelets, organ damage, and potential bleeding.

small clots

77

Abciximab, eptifibatide, and tirofiban share which mechanism?

A. P2Y12 blockade
B. COX inhibition
C. GPIIb/IIIa blockade
D. PDE-3 inhibition

C. GPIIb/IIIa blockade

EAT GP2

78

The platelet receptor blocked by abciximab is best described as the receptor for:

A. ADP
B. Thromboxane
C. Fibrin
D. Collagen

C. Fibrin

79

GPIIb/IIIa signaling is considered the final common pathway for platelet:

A. Production
B. Adhesion
C. Aggregation
D. Activation

C. Aggregation

80

A child with lifelong mucocutaneous bleeding has absent platelet GPIIb/IIIa receptors. Which diagnosis is most likely?

A. Bernard-Soulier syndrome
B. von Willebrand disease
C. Glanzmann thrombasthenia
D. Hemophilia B

C. Glanzmann thrombasthenia

81

Dipyridamole and cilostazol inhibit platelet aggregation primarily by inhibiting:

A. PDE-3
B. COX-1
C. VKORC1
D. Plasmin

A. PDE-3

3 CiDi

82

The platelet-inhibitory effect of dipyridamole and cilostazol is mediated by increased intracellular:

A. cGMP
B. ATP
C. cAMP
D. Calcium

C. cAMP

83

A patient with calf pain during walking is treated with a phosphodiesterase inhibitor that also impairs platelet aggregation. Which drug was most likely used?

A. Ticlopidine
B. Cilostazol
C. Aspirin
D. Abciximab

B. Cilostazol

84

Which treatment is matched correctly with hemophilia A?

A. Alteplase
B. Idelvion
C. Aspirin
D. Eloctate

D. Eloctate

85

Which treatment is matched correctly with hemophilia B?

A. Idelvion
B. Abciximab
C. Desmopressin
D. Alteplase

A. Idelvion

86

A patient with mild hemophilia A needs a temporary increase in factor VIII activity before a minor procedure. Which drug is most appropriate?

A. Clopidogrel
B. Desmopressin acetate
C. Tirofiban
D. Dipyridamole

B. Desmopressin acetate

87

Desmopressin acetate is also useful in which bleeding disorder listed here?

A. Glanzmann thrombasthenia
B. von Willebrand disease
C. Hemophilia B
D. DIC

B. von Willebrand disease

88

A trauma patient with hyperfibrinolytic bleeding is treated with a synthetic drug that competitively inhibits plasminogen activation. Which drug fits best?

A. Tranexamic acid
B. Alteplase
C. Aspirin
D. Abciximab

A. Tranexamic acid

89

Aminocaproic acid and tranexamic acid are best classified as:

A. Fibrinolytics
B. Antiplatelet antibodies
C. Fibrinolysis inhibitors
D. Direct Xa inhibitors

C. Fibrinolysis inhibitors

90

The shared mechanism of aminocaproic acid and tranexamic acid is:

A. Direct plasmin inhibition
B. Competitive plasminogen activation blockade
C. Irreversible COX acetylation
D. GPIIb/IIIa receptor blockade

B. Competitive plasminogen activation blockade

91

A patient receiving abciximab still generates thromboxane A2 normally but cannot complete the final common pathway of platelet plug formation. Which step is being blocked?

A. Platelet aggregation
B. Platelet synthesis
C. vWF release
D. Vitamin K recycling

A. Platelet aggregation